October 25, 2018

IPHA chairs EFPIA Heads of Association meeting

IPHA Chief Executive Oliver O’Connor chaired the recent EFPIA Heads of Association meeting in Vienna, with vice Chair Anders Blanck from Sweden’s LEEM. The meeting took […]
October 24, 2018

Planning on track for Annual Conference as delegates register for ‘lively’ event

Planning is on track for the IPHA Annual Conference and Dinner as delegates register ahead of the November 1 deadline for an event that promises to […]
October 24, 2018

Industry gears up for Brexit

As great uncertainty continues to prevail surrounding the eventual impact of Brexit, the industry is working in the background with relevant public health stakeholders on appropriate  […]
October 22, 2018

Code eLearning site tops 4000 users

A total of 4,191 individual users have trained on the IPHA Code eLearning site since its inception in February 2016. The majority of IPHA member companies […]
October 16, 2018

Pharmacists key to driving a self care strategy

Pharmacists and pharmaceutical industry partner in major Self Care awareness campaign: ‘Be Well this Winter – Think Pharmacy’, to promote a focused approach to better patient […]
October 12, 2018

Industry presses to protect IP Incentives

IPHA is pressing the Irish Government and our MEPs to protect the IP incentives regime which is in danger of erosion by proposed legislation in Brussels. […]
October 9, 2018

Sharp Rise in Health Budget But Patients Still Left Waiting For Innovative Medicines – IPHA

As the Government announced the Budget today [Wednesday], the Irish Pharmaceutical Healthcare Association (IPHA) has said it was very disappointing that enough money could not be […]
September 12, 2018

New President at IPHA

Aidan Lynch, Vice President and General Manager of GSK (Ireland) Limited, has been elected as President of the Irish Pharmaceutical Healthcare Association (IPHA). In this position, […]
August 10, 2018

New Report Backs Biopharma Innovation as Enabler for New Treatments, Jobs and Investments, says IPHA

Protecting Ireland’s innovation policy environment is key to developing new medicines for patients, and to attracting fresh investments in pharmaceutical manufacturing and research, according to a […]